Peter Albers

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Magnetic Resonance

Palliative Care

Top Venues

Healthcare (Basel, Switzerland)

Journal of personalized medicine

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Jan Philipp Radtke, Peter Albers, Boris A Hadaschik, Markus Graefen, Christian P Meyer, Björn Behr, Stephan Nüesch
Value-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a Balanced Score Card. Healthcare (Basel, Switzerland) 12 (10) (2024)
Maxime De Vrieze, Rouvier Al-Monajjed, Matthias Boschheidgen, Peter Albers
Prostate Cancer Screening in Young Men. Journal of personalized medicine 14 (8) (2024)
Jan Philipp Radtke, Peter Albers, Boris A Hadaschik, Markus Graefen, Christian P Meyer, Björn Behr, Stephan Nüesch
Value-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a Balanced Score Card. Healthcare (Basel, Switzerland) 12 (10) (2024)
Jan Philipp Radtke, Peter Albers, Boris A Hadaschik, Markus Graefen, Christian P Meyer, Björn Behr, Stephan Nüesch
Value-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a Balanced Score Card. Healthcare (Basel, Switzerland) 12 (10) (2024)
Emil Novruzov, Dominik Schmitt, Katalin Mattes-György, Markus Beu, Yuriko Mori, Mardjan Dabir, Jan Philipp Radtke, Guenter Niegisch, Peter Albers, Lars Schimmöller, Gerald Antoch, Christina Antke, Frederik L Giesel, Eduards Mamlins
Intra-Individual Comparison of Physiologic [ 68 Ga]Ga-PSMA-11 and [ 18 F]PSMA-1007 Uptake in Ganglia in Patients with Prostate Cancer: A Retrospective, Monocentric Analysis. Cancers 15 (10) (2023)
Felix Bremmer, Pailin Pongratanakul, Margaretha Skowron, Yue Che, Annika Richter, Stefan Küffer, Kirsten Reuter-Jessen, Hanibal Bohnenberger, Stella Pauls, Catena Kresbach, Ulrich Schüller, Kai Stühler, Philipp Ströbel, Peter Albers, Daniel Nettersheim
Characterizing the mutational burden, DNA methylation landscape, and proteome of germ cell tumor-related somatic-type malignancies to identify the tissue-of-origin, mechanisms of therapy resistance, and druggable targets. British journal of cancer (2023)
Volker Arndt, Daniela Doege, Stefan Fröhling, Peter Albers, Hana Algül, Ralf Christian Bargou, Carsten Bokemeyer, Martin Bornhäuser, Christian H Brandts, Peter Brossart, Sara Yvonne Brucker, Tim Henrik Brümmendorf, Hartmut Döhner, Norbert Gattermann, Michael Hallek, Volker Heinemann, Ulrich Keilholz, Thomas Kindler, Cornelia von Levetzow, Florian Lordick, Ulf Peter Neumann, Christoph Peters, Dirk Schadendorf, Stephan Stilgenbauer, Thomas Zander, Daniel Zips, Delia M Braun, Thomas Seufferlein, Gerd Nettekoven, Michael Baumann
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. Journal of cancer research and clinical oncology (2022)
Christian Arsov, Peter Albers, Kathleen Herkommer, Jürgen Gschwend, Florian Imkamp, Inga Peters, Markus Kuczyk, Boris Hadaschik, Glen Kristiansen, Lars Schimmöller, Gerald Antoch, Ernst Rummeny, Frank Wacker, Heinz Schlemmer, Axel Benner, Roswitha Siener, Rudolf Kaaks, Nikolaus Becker
A randomized trial of risk-adapted screening for prostate cancer in young men-Results of the first screening round of the PROBASE trial. International journal of cancer 150 (11) (2022)
Aaron Burmeister, Alexa Stephan, Leandro A Alves Avelar, Melanie R Müller, Andrea Seiwert, Stefan Höfmann, Fabian Fischer, Hector Torres-Gomez, Michèle Janine Hoffmann, Guenter Niegisch, Felix Bremmer, Patrick Petzsch, Karl Köhrer, Peter Albers, Thomas Kurz, Margaretha A Skowron, Daniel Nettersheim
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies. Molecular cancer therapeutics 21 (11) (2022)
Agne Krilaviciute, Peter Albers, Jale Lakes, Jan Philipp Radtke, Kathleen Herkommer, Jürgen Gschwend, Inga Peters, Markus Kuczyk, Stefan A Koerber, Jürgen Debus, Glen Kristiansen, Lars Schimmöller, Gerald Antoch, Marcus Makowski, Frank Wacker, Heinz Schlemmer, Axel Benner, Frederik Giesel, Roswitha Siener, Christian Arsov, Boris Hadaschik, Nikolaus Becker, Rudolf Kaaks
Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trial. International journal of cancer (2022)
Sigrun Holze, Emilie Lemaire, Meinhard Mende, Petra Neuhaus, Vinodh-Kumar-Adithyaa Arthanareeswaran, Michael C Truss, Hoang Minh Do, Anja Dietel, Dogu Teber, Karin D Stützel, Markus Hohenfellner, Robert Rabenalt, Peter Albers, Jens-Uwe Stolzenburg
Quality of life after robotic-assisted and laparoscopic radical prostatectomy: Results of a multicenter randomized controlled trial (LAP-01). The Prostate 82 (8) (2022)
Wasco Wruck, Felix Bremmer, Mara Kotthoff, Alexander Fichtner, Margaretha A Skowron, Stefan Schönberger, Gabriele Calaminus, Christian Vokuhl, David Pfister, Axel Heidenreich, Peter Albers, James Adjaye, Daniel Nettersheim
The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours. Journal of cellular and molecular medicine 25 (3) (2021)
Margaretha A Skowron, Teresa K Becker, Lukas Kurz, Sina Jostes, Felix Bremmer, Florian Fronhoffs, Kai Funke, Gamal A Wakileh, Melanie R Müller, Aaron Burmeister, Thomas Lenz, Anja Stefanski, Kai Stühler, Patrick Petzsch, Karl Köhrer, Peter Altevogt, Peter Albers, Glen Kristiansen, Hubert Schorle, Daniel Nettersheim
The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas. Molecular oncology (2021)
Gabriele Calaminus, Dominik T Schneider, Dietrich von Schweinitz, Heribert Jürgens, Nacera Infed, Stefan Schönberger, Thomas A Olson, Peter Albers, Christian Vokuhl, Raimund Stein, Leendert Looijenga, Jalid Sehouli, Martin Metzelder, Alexander Claviez, Michael Dworzak, Angelika Eggert, Birgit Fröhlich, Nicolas U Gerber, Christian P Kratz, Jörg Faber, Thomas Klingebiel, Dieter Harms, Ulrich Göbel
Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell Biology. Cancers 12 (3) (2020)
Daniël F Osses, Christian Arsov, Lars Schimmöller, Ivo G Schoots, G J L H Geert van Leenders, Irene Esposito, Sebastiaan Remmers, Peter Albers, Monique J Roobol
Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies. Journal of personalized medicine 10 (4) (2020)
Peter Albers, Thomas Wiegel, Heinz Schmidberger, Roswitha Bussar-Maatz, Martin Härter, Glen Kristiansen, Peter Martus, Christoph Meisner, Stefan Wellek, Klaus Grozinger, Peter Renner, Martin Burmester, Fried Schneider, Michael Stöckle
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial. World journal of urology 39 (1) (2020)